Macrophage is a type of versatile cell and being developed as a therapeutic target for multiple diseases. Recent work showed that macrophages, specifically the CD163 + M2 cells, participated in the formation of cell-in-cell structures in human tumors, which may represent a novel mechanism for macrophages/phagocytes to influence tumor development and progression, and potentially help identify novel therapeutic targets for tumor treatment.
Macrophages show great functional diversity in development, homeostasis, tissue repair and immunity etc., which have emerged as important therapeutic targets in many human diseases like cancer, inflammatory disease and fibrosis [1] . It is generally believed that macrophages are designed to engulf pathogens or apoptotic cells and produce trophic factors, immunological mediators and effector molecules that activate immune cells [2] . Meanwhile, tumor-associated macrophages (TAM), a sub-population of macrophages derived from bone marrow, were found important players in tumor progression by influencing multiple processes including angiogenesis, tumor cell invasion, intravasation, extravasation and persistent growth and the like [3] . Recently, macrophages were demonstrated to be involved in the formation of a type of unique cellular structures called cell-in-cell structures (CICs) in human tumor samples [4] , which refreshes our views on the roles of macrophages in tumor biology and potentially provide a novel target for tumor therapy.
Cell-in-cell structure, characterized by internalization of viable cells into other cells, have been documented in various biological processes such as tumorigenesis [5] [6] [7] , inflammation [8] , homeostasis maintenance [9] , virus infection [10, 11] and the forth. CICs are divided into homotypic CICs and heterotypic CICs according to the referred cell types [4, 12] . Formation of homotypic CICs between cells of the same types, usually by entosis, requires cadherin-mediated cell-cell adhesion [6, 13] and the activation of the Rho-ROCK-myosin II pathway [7, 14] , which may mediate competition among human tumor cells and thus promote clonal selection and tumor evolution [7, 15, 16] . The heterotypic cell-in-cell interactions, which have often been referred to as emperipolesis, can occur between host and target cells of diverse cell types [17] and play roles in both physiological and pathological processes. For example, Wang
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et al. [18] demonstrated that internalization of cytotoxic lymphocytes like natural killer (NK) cells into tumor cells requires ezrin and leads to programmed cell-in-cell death termed emperitosis, which may represent an immune evasion mechanism for tumor cells.
In a study on samples from six types of human tumors, Huang et al. [4] analyzed the cell types involved in CICs in human tumors by the "EML" method, where immunofluorescent staining was performed with antibodies against E-cadherin, CD68 and CD45 for Epithelium, Macrophage and Leukocytes (EML), respectively. Consistent with the above classification, they identified both homotypic and heterotypic CICs, whose amounts were comparable (54% vs 46%). While tumor cells (positive in E-cadherin) serve as the major "engulfer" cells (93%), a small number of "engulfer" cells (7%) in CICs were positive in CD68, indicating the participation of macrophages. There seems to be no preference for these macrophages to "engulf" tumor cells (3%, negative in CD45) or leukocytes (4%, positive in CD45). Interestingly, the involved macrophages are positive in CD163, a M2 marker. Although an analysis for clinical correlation was missed due to limited sample number, this study, to our knowledge, provided the first in situ evidence demonstrating the involvement of macrophages in CICs formation in human tumor samples.
The finding that macrophages engulf lymphocytes and tumor cells in human tumor samples raises several interesting issues. First, and the most important, does this type of engulfment influence tumor growth and/or progression? As we know that the resident tumor associated macrophages (TAM) was believed to be tumor promotive via multiple mechanisms, such as stimulating migration, remodeling tumor microenvironment and inducing angiogenesis etc. [1, 3] . Additionally, macrophages could also be immunosuppressive via preventing tumor cells from being attacked by immune cells under certain circumstances [3] . Therefore, it may be an interesting and challenging project to elucidate the pathological significance of macrophage-mediated CICs in human tumors. Second, what are the underlying mechanisms for the role of macrophage-mediated CICs, if any, in human tumors? This question could be addressed from at least two angles. On one hand, similar to tumor cell-mediated cannibalism, macrophages engulf and promote the death of lymphocytes including nature killer cells and cytotoxic T cells, therefore protecting tumor cells from immune attack [3] ; on the other hand, the macrophages that consumed tumor cells could conceivably stimulate immune responses by presenting tumor antigens, thus facilitating clearance of tumor cells. Actually, not only macrophages, tumor cells might also serve as antigenpresenting cells (APC) by internalizing and digesting adjacent tumor cells. In light of this point, the antigen-presentation might be a general function for CICs, which is worth further investigation in the future. Third, but not the last, what factors induce the formation of macrophage-mediated CICs? Although macrophages were abundant in tumor samples, only a small portion of them could form CICs, suggesting that it's a regulated process. Consistent with this notion, macrophagemediated engulfment of tumor cells was found to be controlled by protein-protein interaction on the cell surface, such as CD47-SIRP etc. [19] . Downregulation of CD47 expression on tumor cells or blocking CD47-SIRP interaction could efficiently initiate tumor cell engulfment by macrophages, and importantly, suppress tumor cell growth both in vitro and in animal models. What's more, therapies targeting CICs formation by macrophage have shown promising response in clinical trials [20, 21] . Therefore, exploring the genetic control of CICs formation by macrophage, and tumor cell cannibalism as well, would enable us to develop novel therapeutic strategies for human tumors. Besides, future work on large panel of human tumor samples will help reveal the clinical relevance of CICs and its subtypes.
In addition to tumor, phagocyte-mediated CICs also participate in pathogenesis of other tissues/organs. For example, microglia, the professional phagocyte in brain, could engulf stressed-but-lived neuron cells for death, a process named "phagoptosis" [22] . Phagoptosis was believed to be responsible, at least partially, for neuronal loss during brain development, inflammation, ischemia and neurodegeneration etc. [23] . Thus, macrophages/phagocytes-mediated CICs might represent a general cellular mechanism that has broader implications in human diseases other than tumor.
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